Nature Biotechnology
- 24, 1521 - 1528 (2006)
doi:10.1038/nbt1206-1521
The business of developing antibacterialsJeffrey L Fox
Jeffrey L. Fox is a freelance writer based in Washington D.C.
Although some dazzling technical approaches have fallen short, dozens of small companies and a few major pharmas seek new products for this medically crucial, modest-growth market.
|
